한국학술지인용색인(NRF)
권호기사보기
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
국회도서관 홈으로
정보검색
소장정보 검색
결과 내 검색
동의어 포함
저자 검색
- 검색종류
| 대표형(전거형, Authority) | 생물정보 | 이형(異形, Variant) | 소속 | 직위 | 직업 | 활동분야 | 주기 | 서지 | |
|---|---|---|---|---|---|---|---|---|---|
| 연구/단체명을 입력해주세요. | |||||||||
관련 키워드 검색
- 대표어
- 외국어
|
|
|
|
|
|
주제별 검색
* 주제를 선택하시면 검색 상세로 이동합니다.
권호기사
참고문헌 (304건) : 자료제공( 네이버학술정보 )
| 번호 | 참고문헌 | 국회도서관 소장유무 |
|---|---|---|
| 1 | Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance | 미소장 |
| 2 | Recent advances in nanoparticles-based platforms targeting the PD-1/PD-L1 pathway for cancer treatment | 미소장 |
| 3 | Selenium-driven enhancement of synergistic cancer chemo-/radiotherapy by targeting nanotherapeutics | 미소장 |
| 4 | A tumor microenvironment responsive biodegradable CaCO3/MnO2- based nanoplatform for the enhanced photodynamic therapy and improved PD-L1 immunotherapy | 미소장 |
| 5 | Direct presentation of tumor-associated antigens to induce adaptive immunity by personalized dendritic cell-mimicking nanovaccines | 미소장 |
| 6 | Nanovaccine-based strategies for lymph node targeted delivery and imaging in tumor immunotherapy | 미소장 |
| 7 | NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model | 미소장 |
| 8 | Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine | 미소장 |
| 9 | Multistage-responsive nanovehicle to improve tumor penetration for dual-modality imaging-guided photodynamic-immunotherapy | 미소장 |
| 10 | Lymph node targeting for immunotherapy | 미소장 |
| 11 | Lymph nodes as anti-tumor immunotherapeutic tools: Intranodal-tumor-specific antigen-pulsed dendritic cell vaccine immunotherapy | 미소장 |
| 12 | Manganese-based microcrystals equipped with Ythdf1-targeted biomimetic nanovaccines for reinforced dendritic cell spatiotemporal orchestration | 미소장 |
| 13 | Tumor-associated macrophage polarization in the inflammatory tumor microenvironment | 미소장 |
| 14 | Nanomedicine for cancer immunotherapy: Tracking cancer-specific T-cells in vivo with gold nanoparticles and CT imaging | 미소장 |
| 15 | In vivo T cell-targeting nanoparticle drug delivery systems: Considerations for rational design | 미소장 |
| 16 | The role of toll-like receptor agonists and their nanomedicines for tumor immunotherapy | 미소장 |
| 17 | Nanomedicine targeting the tumor microenvironment: Therapeutic strategies to inhibit angiogenesis, remodel matrix, and modulate immune responses | 미소장 |
| 18 | Gadolinium-based ultra-small nanoparticles augment radiotherapy-induced T-cell response to synergize with checkpoint blockade immunotherapy | 미소장 |
| 19 | A novel therapeutic vaccine based on graphene oxide nanocomposite for tumor immunotherapy | 미소장 |
| 20 | In vivo gold nanoparticle delivery of peptide vaccine induces anti-tumor immune response in prophylactic and therapeutic tumor models | 미소장 |
| 21 | Gold nanoparticle mediated cancer immunotherapy | 미소장 |
| 22 | Boosting tumor immunotherapy by bioactive nanoparticles via Ca2+ interference mediated TME reprogramming and specific PD-L1 depletion | 미소장 |
| 23 | Synergistic effect of tumor chemo-immunotherapy induced by leukocyte-hitchhiking thermal-sensitive micelles | 미소장 |
| 24 | Combination chemotherapeutic and immune-therapeutic anticancer approach via anti-PD-L1 antibody conjugated albumin nanoparticles | 미소장 |
| 25 | Combination of phototherapy with immune checkpoint blockade: Theory and practice in cancer | 미소장 |
| 26 | An optimal portfolio of photothermal combined immunotherapy | 미소장 |
| 27 | A powerful antitumor “trident”: The combination of radio-, immuno- and anti-angiogenesis therapy based on mesoporous silica single coated gold nanoparticles | 미소장 |
| 28 | Gold nanoparticles downregulate interleukin-1β-induced pro-inflammatory responses | 미소장 |
| 29 | Size-dependent attenuation of TLR9 signaling by gold nanoparticles in macrophages | 미소장 |
| 30 | Nanoparticle hydrophobicity dictates immune response | 미소장 |
| 31 | Gold nanoparticles as a vaccine platform: Influence of size and shape on immunological responses in vitro and in vivo | 미소장 |
| 32 | Polyethylenimine hybrid thin-shell hollow mesoporous silica nanoparticles as vaccine self-adjuvants for cancer immunotherapy | 미소장 |
| 33 | Aluminum nanoparticles deliver a dual-epitope peptide for enhanced anti-tumor immunotherapy | 미소장 |
| 34 | Silencing PD-1 and PD-L1 with nanoparticle-delivered small interfering RNA increases cytotoxicity of tumor-infiltrating lymphocytes | 미소장 |
| 35 | Targeting dual gene delivery nanoparticles overcomes immune checkpoint blockade induced adaptive resistance and regulates tumor microenvironment for improved tumor immunotherapy | 미소장 |
| 36 | An antigen-delivery protein nanoparticle combined with anti-PD-1 checkpoint inhibitor has curative efficacy in an aggressive melanoma model | 미소장 |
| 37 | Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death | 미소장 |
| 38 | Polyelectrolyte multilayers assembled entirely from immune signals on gold nanoparticle templates promote antigen-specific T cell response | 미소장 |
| 39 | Engineering a smart agent for enhanced immunotherapy effect by simultaneously blocking PD-L1 and CTLA-4 | 미소장 |
| 40 | Hybrid spherical nucleotide nanoparticles can enhance the synergistic anti-tumor effect of CTLA-4 and PD-1 blockades | 미소장 |
| 41 | Degradable drug carriers: Vanishing mesoporous silica nanoparticles | 미소장 |
| 42 | Alternative activation of macrophages through interleukin-13-loaded extra-large-pore mesoporous silica nanoparticles suppresses experimental autoimmune encephalomyelitis | 미소장 |
| 43 | The role interplay between mesoporous silica pore volume and surface area and their effect on drug loading capacity | 미소장 |
| 44 | Multicomponent siRNA/miRNA-loaded modified mesoporous silica nanoparticles targeted bladder cancer for a highly effective combination therapy | 미소장 |
| 45 | Injectable dual-scale mesoporous silica cancer vaccine enabling efficient delivery of antigen/adjuvant-loaded nanoparticles to dendritic cells recruited in local macroporous scaffold | 미소장 |
| 46 | Mesoporous silica nanoparticles act as a self-adjuvant for ovalbumin model antigen in mice | 미소장 |
| 47 | The pore size of mesoporous silica nanoparticles regulates their antigen delivery efficiency | 미소장 |
| 48 | Janus silica nanoparticle-based tumor microenvironment modulator for restoring tumor sensitivity to programmed cell death ligand 1 immune checkpoint blockade therapy | 미소장 |
| 49 | Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics | 미소장 |
| 50 | Iron oxide nanoparticles for magnetically-guided and magnetically-responsive drug delivery | 미소장 |
| 51 | Dimercaptosuccinic acid-coated magnetite nanoparticles for magnetically guided in vivo delivery of interferon gamma for cancer immunotherapy | 미소장 |
| 52 | A multifunctional core–shell nanoparticle for dendritic cell-based cancer immunotherapy | 미소장 |
| 53 | Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles | 미소장 |
| 54 | Influence of coating and size of magnetic nanoparticles on cellular uptake for in vitro MRI | 미소장 |
| 55 | Paclitaxel-loaded iron oxide nanoparticles for targeted breast cancer therapy | 미소장 |
| 56 | Carbon nanomaterials for drug delivery and tissue engineering | 미소장 |
| 57 | Functionalization of carbon nanomaterials for biomedical applications | 미소장 |
| 58 | Drug delivery with carbon-based nanomaterials as versatile nanocarriers: Progress and prospects | 미소장 |
| 59 | Toward carbon-nanotube-based theranostic agents for microwave detection and treatment of breast cancer: Enhanced dielectric and heating response of tissue-mimicking materials | 미소장 |
| 60 | Single-walled carbon nanotubes as a photo-thermo-acoustic cancer theranostic agent: Theory and proof of the concept experiment | 미소장 |
| 61 | NIR light-triggered chemo-phototherapy by ICG functionalized MWNTs for synergistic tumor-targeted delivery | 미소장 |
| 62 | Temperature-sensitive lipid-coated carbon nanotubes for synergistic photothermal therapy and gene therapy | 미소장 |
| 63 | Dual stimulation of antigen presenting cells using carbon nanotube-based vaccine delivery system for cancer immunotherapy | 미소장 |
| 64 | Carbon nanotubes enhance CpG uptake and potentiate antiglioma immunity | 미소장 |
| 65 | Enhanced cellular activation with single walled carbon nanotube bundles presenting antibody stimuli | 미소장 |
| 66 | Clustering of stimuli on single-walled carbon nanotube bundles enhances cellular activation | 미소장 |
| 67 | Progress in the functional modification of graphene/graphene oxide: A review | 미소장 |
| 68 | Structural characterization of graphene oxide: Surface functional groups and fractionated oxidative debris | 미소장 |
| 69 | Applications of π-π stacking interactions in the design of drug-delivery systems | 미소장 |
| 70 | In situ transforming RNA nanovaccines from polyethylenimine functionalized graphene oxide hydrogel for durable cancer immunotherapy | 미소장 |
| 71 | Engineered fluorescent carbon dots as promising immune adjuvants to efficiently enhance cancer immunotherapy | 미소장 |
| 72 | Preparation and application of calcium phosphate nanocarriers in drug delivery | 미소장 |
| 73 | Charge reversible calcium phosphate lipid hybrid nanoparticle for siRNA delivery | 미소장 |
| 74 | Disulfiram loaded calcium phosphate nanoparticles for enhanced cancer immunotherapy | 미소장 |
| 75 | Risedronate-functionalized manganese-hydroxyapatite amorphous particles: A potent adjuvant for subunit vaccines and cancer immunotherapy | 미소장 |
| 76 | ATP stabilised and sensitised calcium phosphate nanoparticles as effective adjuvants for a DNA vaccine against cancer | 미소장 |
| 77 | Manganese-based advanced nanoparticles for biomedical applications: Future opportunity and challenges | 미소장 |
| 78 | Multifunctional albumin–MnO2 nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response | 미소장 |
| 79 | Applications and biological activity of nanoparticles of manganese and manganese oxides in in vitro and in vivo models | 미소장 |
| 80 | Integration of manganese dioxide-based nanomaterials for biomedical applications | 미소장 |
| 81 | Design of hybrid biocatalysts by controlled heteroaggregation of manganese oxide and sulfate latex particles to combat reactive oxygen species | 미소장 |
| 82 | Biodistribution and acute toxicity of a nanofluid containing manganese iron oxide nanoparticles produced by a mechanochemical process | 미소장 |
| 83 | Biomineralized MnO2 nanoplatforms mediated delivery of immune checkpoint inhibitors with STING pathway activation to potentiate cancer radio-immunotherapy | 미소장 |
| 84 | MnO2 nanoparticles as a minimalist multimode vaccine adjuvant/delivery system to regulate antigen presenting cells for tumor immunotherapy | 미소장 |
| 85 | Manganese oxide nanoparticles as MRI contrast agents in tumor multimodal imaging and therapy | 미소장 |
| 86 | Biocompatible and bioactivable terpolymer-lipid-MnO2 nanoparticle-based MRI contrast agent for improving tumor detection and delineation | 미소장 |
| 87 | PD-1/PD-L1 axis in organ fibrosis | 미소장 |
| 88 | Targets of immune escape mechanisms in cancer: Basis for development and evolution of cancer immune checkpoint inhibitors | 미소장 |
| 89 | Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy | 미소장 |
| 90 | PD-1/PD-L1 pathway: Current researches in cancer | 미소장 |
| 91 | Crosstalk between the tumor microenvironment and cancer cells: A promising predictive biomarker for immune checkpoint inhibitors | 미소장 |
| 92 | Immune checkpoint inhibitors in clinical trials | 미소장 |
| 93 | Review of the immune checkpoint inhibitors in the context of cancer treatment | 미소장 |
| 94 | Adverse effects of immune-checkpoint inhibitors: Epidemiology, management and surveillance | 미소장 |
| 95 | Immune-related adverse events and the balancing act of immunotherapy | 미소장 |
| 96 | Is PD-L1 a consistent biomarker for anti-PD-1 therapy? The model of balstilimab in a virally-driven tumor | 미소장 |
| 97 | PD-1 and PD-L1 correlated gene expression profiles and their association with clinical outcomes of breast cancer | 미소장 |
| 98 | PD-L1 distribution and perspective for cancer immunotherapy—Blockade, knockdown, or inhibition | 미소장 |
| 99 | Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway | 미소장 |
| 100 | Study and analysis of antitumor resistance mechanism of PD1/PD-L1 immune checkpoint blocker | 미소장 |
| 101 | Resistance to PD-1/PD-L1 blockade cancer immunotherapy: Mechanisms, predictive factors, and future perspectives | 미소장 |
| 102 | Intact polyaniline coating as a conductive guidance is beneficial to repairing sciatic nerve injury | 미소장 |
| 103 | Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer | 미소장 |
| 104 | Sustained and targeted delivery of checkpoint inhibitors by metal-organic frameworks for cancer immunotherapy | 미소장 |
| 105 | Targeting small molecule drugs to T cells with antibody-directed cell-penetrating gold nanoparticles | 미소장 |
| 106 | NIR-light-mediated spatially selective triggering of anti-tumor immunity via upconversion nanoparticle-based immunodevices | 미소장 |
| 107 | Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment | 미소장 |
| 108 | Effects of gold nanoprism-assisted human PD-L1 siRNA on both gene down-regulation and photothermal therapy on lung cancer | 미소장 |
| 109 | Comparing the variants of iron oxide nanoparticle-mediated delivery of miRNA34a for efficiency in silencing of PD-L1 genes in cancer cells | 미소장 |
| 110 | Photothermal-activatable Fe3O4 superparticle nanodrug carriers with PD-L1 immune checkpoint blockade for anti-metastatic cancer immunotherapy | 미소장 |
| 111 | Enhancement of anti-PD-1/PD-L1 immunotherapy for osteosarcoma using an intelligent autophagy-controlling metal organic framework | 미소장 |
| 112 | Inhalable metal–organic framework-mediated cuproptosis combined with PD-L1 checkpoint blockade for lung metastasis synergistic immunotherapy | 미소장 |
| 113 | Anti-tumor immunity and ferroptosis of hepatocellular carcinoma are enhanced by combined therapy of sorafenib and delivering modified GO-based PD-L1 siRNAs | 미소장 |
| 114 | Human iPS cells loaded with MnO2-based nanoprobes for photodynamic and simultaneous enhanced immunotherapy against cancer | 미소장 |
| 115 | Dendritic cell-activating magnetic nanoparticles enable early prediction of antitumor response with magnetic resonance imaging | 미소장 |
| 116 | Understanding the CD28/CTLA-4 (CD152) pathway and its implications for costimulatory blockade | 미소장 |
| 117 | CTLA-4, an essential immune-checkpoint for T-cell activation | 미소장 |
| 118 | CTLA-4: A moving target in immunotherapy | 미소장 |
| 119 | Challenges and opportunities in targeting the CD28/CTLA-4 pathway in transplantation and autoimmunity | 미소장 |
| 120 | In silico engineering a CD80 variant with increased affinity to CTLA-4 and decreased affinity to CD28 for optimized cancer immunotherapy | 미소장 |
| 121 | Adverse event profiles of anti-CTLA-4 and anti-PD-1 monoclonal antibodies alone or in combination: Analysis of spontaneous reports submitted to FAERS | 미소장 |
| 122 | Immunological responses triggered by photothermal therapy with carbon nanotubes in combination with anti-CTLA-4 therapy to inhibit cancer metastasis | 미소장 |
| 123 | A smart responsive nanotheranostic system for MRI of tumor response to immunotherapy and enhanced synergism of thermo-immunotherapy | 미소장 |
| 124 | Evoking tumor associated macrophages by mitochondria-targeted magnetothermal immunogenic cell death for cancer immunotherapy | 미소장 |
| 125 | Dendritic cell–based immunotherapy: State of the art and beyond | 미소장 |
| 126 | Dendritic cell-based immunotherapy | 미소장 |
| 127 | Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy | 미소장 |
| 128 | Ex vivo activation of dendritic cells via coacervate-mediated exogenous tumor cell lysate delivery | 미소장 |
| 129 | Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: A prospective patients’ preference-based study (PPPS) | 미소장 |
| 130 | Cationic nanoparticles enhance T cell tumor infiltration and antitumor immune responses to a melanoma vaccine | 미소장 |
| 131 | Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells | 미소장 |
| 132 | Genetic engineering of dendritic cells using partially zwitterionic dendrimer-entrapped gold nanoparticles boosts efficient tumor immunotherapy | 미소장 |
| 133 | Covalent conjugation of small-molecule adjuvants to nanoparticles induces robust cytotoxic T cell responses via DC activation | 미소장 |
| 134 | Enhanced stimulation of anti-ovarian cancer CD8+ T cells by dendritic cells loaded with nanoparticle encapsulated tumor antigen | 미소장 |
| 135 | Improving cancer immunotherapy by cell membrane-camouflaged nanoparticles | 미소장 |
| 136 | Artificial mini dendritic cells boost T cell–based immunotherapy for ovarian cancer | 미소장 |
| 137 | Recent advances in cell membrane-derived biomimetic nanotechnology for cancer immunotherapy | 미소장 |
| 138 | Regulatory T cells in tumor microenvironment: New mechanisms, potential therapeutic strategies and future prospects | 미소장 |
| 139 | CAR-T cell therapy: Current limitations and potential strategies | 미소장 |
| 140 | In-vivo induced CAR-T cell for the potential breakthrough to overcome the barriers of current CAR-T cell therapy | 미소장 |
| 141 | Nanotechnology-based CAR-T strategies for improving efficacy and safety of tumor immunotherapy | 미소장 |
| 142 | Macrophage polarization states in the tumor microenvironment | 미소장 |
| 143 | Shaping polarization of tumor-associated macrophages in cancer immunotherapy | 미소장 |
| 144 | Macrophages in immunoregulation and therapeutics | 미소장 |
| 145 | Antitumor strategies targeting macrophages: The importance of considering the differences in differentiation/polarization processes between human and mouse macrophages | 미소장 |
| 146 | Targeting macrophages in cancer immunotherapy | 미소장 |
| 147 | Macrophage reprogramming and cancer therapeutics: Role of iNOS-derived NO. | 미소장 |
| 148 | Macrophage achieves self-protection against oxidative stress-induced ageing through the Mst-Nrf2 axis | 미소장 |
| 149 | Reactive oxygen species in macrophages: Sources and targets | 미소장 |
| 150 | Metabolism via arginase or nitric oxide synthase: Two competing arginine pathways in macrophages | 미소장 |
| 151 | The role of polyamines in the regulation of macrophage polarization and function | 미소장 |
| 152 | Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a toll-like receptor agonist-conjugated peptide | 미소장 |
| 153 | New insights into M1/M2 macrophages: Key modulators in cancer progression | 미소장 |
| 154 | Pollen-mimetic metal–organic frameworks with tunable spike-like nanostructures that promote cell interactions to improve antigen-specific humoral immunity | 미소장 |
| 155 | Facile synthesis of uniform virus-like mesoporous silica nanoparticles for enhanced cellular internalization | 미소장 |
| 156 | Endotoxin nanovesicles: Hydrophilic gold nanodots control supramolecular lipopolysaccharide assembly for modulating immunological responses | 미소장 |
| 157 | Cancer-associated fibroblasts in the single-cell era | 미소장 |
| 158 | Biomarkers for cancer-associated fibroblasts | 미소장 |
| 159 | Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer | 미소장 |
| 160 | Modulation of the antitumor immune response by cancer-associated fibroblasts: Mechanisms and targeting strategies to hamper their immunosuppressive functions | 미소장 |
| 161 | Cancer-associated fibroblasts: An emerging target of anti-cancer immunotherapy | 미소장 |
| 162 | CAFs orchestrates tumor immune microenvironment—A new target in cancer therapy | 미소장 |
| 163 | Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy | 미소장 |
| 164 | Targeting CXCL12/CXCR4 axis in tumor immunotherapy | 미소장 |
| 165 | Intra-lymph node injection of biodegradable polymer particles | 미소장 |
| 166 | Use of a lymphatic drug delivery system and sonoporation to target malignant metastatic breast cancer cells proliferating in the marginal sinuses | 미소장 |
| 167 | Nanoparticles targeting lymph nodes for cancer immunotherapy: Strategies and influencing factors | 미소장 |
| 168 | Engineering nano- and microparticles to tune immunity | 미소장 |
| 169 | Efficient nanovaccine delivery in cancer immunotherapy | 미소장 |
| 170 | Intranodal immunization with tumor lysate-pulsed dendritic cells enhances protective antitumor Immunity1 | 미소장 |
| 171 | Immunologic and clinical effects of injecting mature peptide-loaded dendritic cells by intralymphatic and intranodal routes in metastatic melanoma patients | 미소장 |
| 172 | Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigen | 미소장 |
| 173 | Local immunotherapy of cancer: Innovative approaches to harnessing tumor-specific immune responses | 미소장 |
| 174 | Intranodal delivery of modified docetaxel: Innovative therapeutic method to inhibit tumor cell growth in lymph nodes | 미소장 |
| 175 | The impact of size on particle drainage dynamics and antibody response | 미소장 |
| 176 | Size-dependent lymphatic uptake of nanoscale-tailored particles as tumor mass increases | 미소장 |
| 177 | Critical size limit of biodegradable nanoparticles for enhanced lymph node trafficking and paracortex penetration | 미소장 |
| 178 | Nanoparticle surface charge impacts distribution, uptake and lymph node trafficking by pulmonary antigen-presenting cells | 미소장 |
| 179 | Physical and chemical profiles of nanoparticles for lymphatic targeting | 미소장 |
| 180 | Extracellular matrix remodeling in tumor progression and immune escape: From mechanisms to treatments | 미소장 |
| 181 | Extracellular matrix in the tumor microenvironment and its impact on cancer therapy | 미소장 |
| 182 | Microenvironmental regulation of tumor progression and metastasis | 미소장 |
| 183 | The role of tumor microenvironment in cancer metastasis: Molecular mechanisms and therapeutic opportunities | 미소장 |
| 184 | Tumor microenvironment complexity and therapeutic implications at a glance | 미소장 |
| 185 | Metabolic remodeling as a way of adapting to tumor microenvironment (TME), a job of several holders | 미소장 |
| 186 | Metabolic adaptations of cancer in extreme tumor microenvironments | 미소장 |
| 187 | Targeting the tumor microenvironment: Potential strategy for cancer therapeutics | 미소장 |
| 188 | Targeting the tumor microenvironment: Removing obstruction to anticancer immune responses and immunotherapy | 미소장 |
| 189 | Chronic inflammation, cancer development and immunotherapy | 미소장 |
| 190 | Inflammation and tumor progression: Signaling pathways and targeted intervention | 미소장 |
| 191 | Immunosuppressive cells in cancer: Mechanisms and potential therapeutic targets | 미소장 |
| 192 | Targeting tumor microenvironment by small-molecule inhibitors | 미소장 |
| 193 | Aptamer-based smart targeting and spatial trigger–response drug-delivery systems for anticancer therapy | 미소장 |
| 194 | Tumor microenvironment-responsive nanoparticles for cancer theragnostic applications | 미소장 |
| 195 | Approaches to improve EPR-based drug delivery for cancer therapy and diagnosis | 미소장 |
| 196 | Intratumoral immunotherapy: Using the tumour against itself | 미소장 |
| 197 | Intratumoural administration and tumour tissue targeting of cancer immunotherapies | 미소장 |
| 198 | Intratumoral immunotherapy: Using the tumor as the remedy | 미소장 |
| 199 | Cancer immunotherapy dosing: A pharmacokinetic/pharmacodynamic perspective | 미소장 |
| 200 | Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanoma | 미소장 |
| 201 | Nanomaterial-based tumor photothermal immunotherapy | 미소장 |
| 202 | Immuno-photodynamic therapy (IPDT): Organic photosensitizers and their application in cancer ablation | 미소장 |
| 203 | Chemo-immunotherapy: A new trend in cancer treatment | 미소장 |
| 204 | Radiotherapy combined with immunotherapy: The dawn of cancer treatment | 미소장 |
| 205 | Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review | 미소장 |
| 206 | Immunogenic cell death-inducing chemotherapeutic nanoformulations potentiate combination chemoimmunotherapy | 미소장 |
| 207 | Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency | 미소장 |
| 208 | Immunogenic cell death: A step ahead of autophagy in cancer therapy | 미소장 |
| 209 | Induction of immunogenic cell death by novel platinum-based anticancer agents | 미소장 |
| 210 | Combining immune checkpoint blockade with ATP-based immunogenic cell death amplifier for cancer chemo-immunotherapy | 미소장 |
| 211 | Dendritic cell subsets in cancer immunity and tumor antigen sensing | 미소장 |
| 212 | Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses | 미소장 |
| 213 | Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy | 미소장 |
| 214 | Detection of immunogenic cell death and its relevance for cancer therapy | 미소장 |
| 215 | Gemcitabine modulates HLA-I regulation to improve tumor antigen presentation by pancreatic cancer cells | 미소장 |
| 216 | Biologically responsive plasmonic assemblies for second near-infrared window photoacoustic imaging-guided concurrent chemo-immunotherapy | 미소장 |
| 217 | Tumor microenvironment-activated nanoparticles loaded with an iron-carbonyl complex for chemodynamic immunotherapy of lung metastasis of melanoma in vivo | 미소장 |
| 218 | Coordination and redox dual-responsive mesoporous organosilica nanoparticles amplify immunogenic cell death for cancer chemoimmunotherapy | 미소장 |
| 219 | Biomimetic diselenide-bridged mesoporous organosilica nanoparticles as an X-ray-responsive biodegradable carrier for chemo-immunotherapy | 미소장 |
| 220 | Reinforcing the induction of immunogenic cell death via artificial engineered cascade bioreactor-enhanced chemo-immunotherapy for optimizing cancer immunotherapy | 미소장 |
| 221 | Radiation therapy and anti-tumor immunity: Exposing immunogenic mutations to the immune system | 미소장 |
| 222 | Current approaches for combination therapy of cancer: The role of immunogenic cell death | 미소장 |
| 223 | Application of hyperthermia in addition to ionizing irradiation fosters necrotic cell death and HMGB1 release of colorectal tumor cells | 미소장 |
| 224 | Bip inhibition in glioma stem cells promotes radiation-induced immunogenic cell death | 미소장 |
| 225 | Amplifying “eat me signal” by immunogenic cell death for potentiating cancer immunotherapy | 미소장 |
| 226 | Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy | 미소장 |
| 227 | The impact of radiation-induced DNA damage on cGAS-STING-mediated immune responses to cancer | 미소장 |
| 228 | DNA base damage by reactive oxygen species, oxidizing agents, and UV radiation | 미소장 |
| 229 | (Reference title not available) | 미소장 |
| 230 | Radiation therapy and myeloid-derived suppressor cells: Breaking down their cancerous partnership | 미소장 |
| 231 | Radiotherapy both promotes and inhibits myeloid-derived suppressor cell function: Novel strategies for preventing the tumor-protective effects of radiotherapy | 미소장 |
| 232 | Radionuclide labeled gold nanoclusters boost effective anti-tumor immunity for augmented radio-immunotherapy of cancer | 미소장 |
| 233 | Synergistic local combination of radiation and anti-programmed death ligand 1 immunotherapy using radiation-responsive splintery metallic nanocarriers | 미소장 |
| 234 | Nanoparticle-mediated radiotherapy remodels the tumor microenvironment to enhance antitumor efficacy | 미소장 |
| 235 | Photodynamic and photothermal therapies: Synergy opportunities for nanomedicine | 미소장 |
| 236 | Insight into the prospects for tumor therapy based on photodynamic immunotherapy | 미소장 |
| 237 | Photodynamic immunotherapy of cancers based on nanotechnology: Recent advances and future challenges | 미소장 |
| 238 | A facile strategy of boosting photothermal conversion efficiency through state transformation for cancer therapy | 미소장 |
| 239 | Enhancing the efficiency of mild-temperature photothermal therapy for cancer assisting with various strategies | 미소장 |
| 240 | Furin-instructed intracellular gold nanoparticle aggregation for tumor photothermal therapy | 미소장 |
| 241 | Polydopamine-coated mesoporous silica nanoparticles for multi-responsive drug delivery and combined chemo-photothermal therapy | 미소장 |
| 242 | Recent development of polydopamine anti-bacterial nanomaterials | 미소장 |
| 243 | Singlet oxygen, photodynamic therapy, and mechanisms of cancer cell death | 미소장 |
| 244 | Photochromic materials as a photosensitizer in reversible reactive singlet oxygen generation | 미소장 |
| 245 | Facile development of biodegradable polymer-based nanotheranostics: Hydrophobic photosensitizers delivery, fluorescence imaging and photodynamic therapy | 미소장 |
| 246 | Delivery of a hydrophobic phthalocyanine photosensitizer using PEGylated gold nanoparticle conjugates for the in vivo photodynamic therapy of amelanotic melanoma | 미소장 |
| 247 | Water-insoluble photosensitizer nanocolloids stabilized by supramolecular interfacial assembly towards photodynamic therapy | 미소장 |
| 248 | Inorganic nanoparticles in clinical trials and translations | 미소장 |
| 249 | Cancer immunotherapy update: FDA-approved checkpoint inhibitors and companion diagnostics | 미소장 |
| 250 | 200 NBTXR3 nanoparticle with immunoradiation improves survival and generates long-term anti-tumor memory in an anti-PD1 resistant murine lung cancer model | 미소장 |
| 251 | A phase I trial evaluating NBTXR3 activated by radiotherapy in combination with nivolumab or pembrolizumab in patients with advanced cancers | 미소장 |
| 252 | Immune checkpoint signaling and cancer immunotherapy | 미소장 |
| 253 | Hot and cold tumors: Immunological features and the therapeutic strategies | 미소장 |
| 254 | Turning cold tumors into hot tumors by improving T-cell infiltration | 미소장 |
| 255 | Advanced nanotechnology for enhancing immune checkpoint blockade therapy | 미소장 |
| 256 | Cell membrane-camouflaged inorganic nanoparticles for cancer therapy | 미소장 |
| 257 | Cell membrane-camouflaged nanoparticles: A promising biomimetic strategy for cancer theragnostics | 미소장 |
| 258 | Metal nanoparticles for photodynamic therapy: A potential treatment for breast cancer | 미소장 |
| 259 | Nanoparticles for imaging-guided photothermal therapy of colorectal cancer | 미소장 |
| 260 | Self-adjuvanting cancer nanovaccines | 미소장 |
| 261 | Photothermally enhanced photodynamic therapy based on glutathione-responsive pheophorbide a-conjugated gold nanorod formulations for cancer theranostic applications | 미소장 |
| 262 | Regulation of human macrophage M1-M2 polarization balance by hypoxia and the triggering receptor expressed on myeloid cells-1 | 미소장 |
| 263 | Dual-responsive core–shell tecto dendrimers enable efficient gene editing of cancer cells to boost immune checkpoint blockade therapy | 미소장 |
| 264 | Isorhamnetin and anti-PD-L1 antibody dual-functional mesoporous silica nanoparticles improve tumor immune microenvironment and inhibit YY1-mediated tumor progression | 미소장 |
| 265 | Construction of hierarchically biomimetic iron oxide nanosystems for macrophage repolarization-promoted immune checkpoint blockade of cancer immunotherapy | 미소장 |
| 266 | Magnetic metal micelles for enhanced delivery of self-immolating CD8+ T-cell epitopes for cancer immunotherapy | 미소장 |
| 267 | Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer | 미소장 |
| 268 | Tumor microenvironment-activable manganese-boosted catalytic immunotherapy combined with PD-1 checkpoint blockade | 미소장 |
| 269 | Manganese-based nanoactivator optimizes cancer immunotherapy via enhancing innate immunity | 미소장 |
| 270 | Intracellularly generated immunological gold nanoparticles for combinatorial photothermal therapy and immunotherapy against tumor | 미소장 |
| 271 | Visible-light-triggered prodrug nanoparticles combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy | 미소장 |
| 272 | Photothermally controlled MHC class I restricted CD8+ T-cell responses elicited by hyaluronic acid decorated gold nanoparticles as a vaccine for cancer immunotherapy | 미소장 |
| 273 | Gold nanoparticles coimmobilized with small molecule toll-like receptor 7 ligand and α-mannose as adjuvants | 미소장 |
| 274 | Partially PEGylated dendrimer-entrapped gold nanoparticles: A promising nanoplatform for highly efficient DNA and siRNA delivery | 미소장 |
| 275 | Nanoparticle-mediated delivery of STAT3 inhibitors in the treatment of lung cancer | 미소장 |
| 276 | Aggregable nanoparticles-enabled chemotherapy and autophagy inhibition combined with anti-PD-L1 antibody for improved glioma treatment | 미소장 |
| 277 | Extra-large pore mesoporous silica nanoparticles enabling co-delivery of high amounts of protein antigen and toll-like receptor 9 agonist for enhanced cancer vaccine efficacy | 미소장 |
| 278 | Synergistic effects of stellated fibrous mesoporous silica and synthetic dsRNA analogues for cancer immunotherapy | 미소장 |
| 279 | Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy | 미소장 |
| 280 | Translatable drug-loaded iron oxide nanophore sensitizes murine melanoma tumors to monoclonal antibody immunotherapy | 미소장 |
| 281 | Functionalized graphene oxide serves as a novel vaccine nano-adjuvant for robust stimulation of cellular immunity | 미소장 |
| 282 | Efficient lymph node-targeted delivery of personalized cancer vaccines with reactive oxygen species-inducing reduced graphene oxide nanosheets | 미소장 |
| 283 | Construction of Durvalumab/carbon nanotube/PEI/aptamer-siRNA chimera for the immunotherapy of hepatocellular carcinoma | 미소장 |
| 284 | Tailoring the architecture of cationic polymer brush-modified carbon nanotubes for efficient siRNA delivery in cancer immunotherapy | 미소장 |
| 285 | Carbon dots and tumor antigen conjugates as nanovaccines for elevated cancer immunotherapy | 미소장 |
| 286 | Spleen-targeted mRNA delivery by amphiphilic carbon dots for tumor immunotherapy | 미소장 |
| 287 | Targeted degradation of PD-L1 and activation of the STING pathway by carbon-dot-based PROTACs for cancer immunotherapy | 미소장 |
| 288 | Calcium phosphate nanoneedle based gene delivery system for cancer genetic immunotherapy | 미소장 |
| 289 | Zoledronic acid conjugated calcium phosphate nanoparticles for applications in cancer immunotherapy | 미소장 |
| 290 | Manganese-enriched zinc peroxide functional nanoparticles for potentiating cancer immunotherapy | 미소장 |
| 291 | Multifunctional calcium–manganese nanomodulator provides antitumor treatment and improved immunotherapy via reprogramming of the tumor microenvironment | 미소장 |
| 292 | Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer | 미소장 |
| 293 | Transformable honeycomb-like nanoassemblies of carbon dots for regulated multisite delivery and enhanced antitumor chemoimmunotherapy | 미소장 |
| 294 | Multifunctional tumor-targeting carbon dots for tumor microenvironment activated ferroptosis and immunotherapy in cancer treatment | 미소장 |
| 295 | Emerging theranostic gold nanostructures to combat cancer: Novel probes for combinatorial immunotherapy and photothermal therapy | 미소장 |
| 296 | Synergistic interventional photothermal therapy and immunotherapy using an iron oxide nanoplatform for the treatment of pancreatic cancer | 미소장 |
| 297 | Engineering platelets with PDL1 antibodies and iron oxide nanoparticles for postsurgical cancer immunotherapy | 미소장 |
| 298 | Polydopamine-coated ferric oxide nanoparticles for R848 delivery for photothermal immunotherapy in breast cancer | 미소장 |
| 299 | Immunostimulatory oligonucleotides-loaded cationic graphene oxide with photothermally enhanced immunogenicity for photothermal/immune cancer therapy | 미소장 |
| 300 | Photo-activated chemo-immunotherapy for metastatic cancer using a synergistic graphene nanosystem | 미소장 |
| 301 | Immunoinducible carbon dot-incorporated hydrogels as a photothermal-derived antigen depot to trigger a robust antitumor immune response | 미소장 |
| 302 | Immunogenic cell death augmented by manganese zinc sulfide nanoparticles for metastatic melanoma immunotherapy | 미소장 |
| 303 | A size-tunable nanoplatform: Enhanced MMP2-activated chemo-photodynamic immunotherapy based on biodegradable mesoporous silica nanoparticles | 미소장 |
| 304 | Immunomodulation of tumor microenvironment by arginine-loaded iron oxide nanoparticles for gaseous immunotherapy | 미소장 |
MARC 보기
오류 데이터 정정요청
*표시는 필수 입력사항입니다.
알림톡 발송
| 전화번호 |
|---|
개인정보 수정 바로가기
연속간행물 권호 선택
우편복사 안내
- ◾ 도서관을 방문하지 못할 경우 인터넷, 팩스 등으로 자료 복사를 신청하고, 복사물을 우편·팩스 등으로 제공받는 서비스
- ◾ 대상자료: 일반도서, 연속간행물 및 학위논문
- ※ 고서, 고잡지, 훼손될 우려가 있는 자료, 마이크로폼 자료 및 신문 등 제외
- ◾ 신청 책수: 1인 5책 이하(1일 기준)
- ◾ 신청 절차: 자료 검색 → 우편복사 목록담기 → 복사 범위 입력 → 우편복사 주문서 입력 → 접수 및 확인
- ※ 저작권법에 의거하여 부분 복사(전체 페이지 수의 1/3 범위 이내)만 가능
- ◾ 복사 범위 입력 예시: (연속 페이지) 1-30, (부분 페이지) 25, 30-40
| 번호 | 발행일자 | 권호명 | 제본정보 | 자료실 | 원문 | 신청 페이지 |
|---|
도서위치안내(서울관)
도서위치안내: / 서가번호:
0
확인
우편복사 목록담기를 완료하였습니다.
내서재에 담기
새로운 서재
*표시는 필수 입력사항입니다.
저장
저장 되었습니다.